We are live on ! Find out more
GDRX icon

GoodRx Holdings

168 hedge funds and large institutions have $988M invested in GoodRx Holdings in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 40 increasing their positions, 46 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $6.04M | Put options by funds: $3.95M

19% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 32

4.59% more ownership

Funds ownership: 139.73%144.32% (+4.6%)

2% more funds holding

Funds holding: 165168 (+3)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

4% less capital invested

Capital invested by funds: $1.03B → $988M (-$40.7M)

13% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 46

Holders
168
Holders Change
+3
Holders Change %
+1.82%
% of All Funds
2.41%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
38
Increased
40
Reduced
46
Closed
32
Calls
$6.04M
Puts
$3.95M
Net Calls
+$2.09M
Net Calls Change
+$1.02M
Name Holding Trade Value Shares
Change
Change in
Stake
ASRS
101
Arizona State Retirement System
Arizona
$160K +$7.03K +896 +4%
A
102
AlphaQuest
New York
$160K +$181K +23,044 New
WG
103
Winton Group
United Kingdom
$131K +$149K +18,934 New
QT
104
Quantbot Technologies
New York
$127K -$75.5K -9,625 -34%
RIP
105
RAM Investment Partners
Washington
$121K
Zurich Cantonal Bank
106
Zurich Cantonal Bank
Switzerland
$111K
DFCM
107
Dark Forest Capital Management
Puerto Rico
$97.9K +$24.2K +3,078 +28%
Verition Fund Management
108
Verition Fund Management
Connecticut
$97.4K -$248K -31,562 -69%
GAM
109
Gotham Asset Management
New York
$93.7K -$1.4K -178 -1%
PCH
110
Polar Capital Holdings
United Kingdom
$85.8K +$97K +12,360 New
Handelsbanken Fonder
111
Handelsbanken Fonder
Sweden
$78K
Walleye Capital
112
Walleye Capital
New York
$76.6K -$152K -19,305 -64%
VT
113
Vise Technologies
New York
$75.3K +$85.2K +10,855 New
EWA
114
EP Wealth Advisors
California
$73.2K +$82.8K +10,547 New
Victory Capital Management
115
Victory Capital Management
Texas
$71.1K +$1.62K +206 +2%
AF
116
Advisornet Financial
Minnesota
$69.4K +$23.5K +3,000 +43%
NEI
117
Northwest & Ethical Investments
Ontario, Canada
$68.7K -$40K -5,100 -34%
SA
118
Sanctuary Advisors
Indiana
$60.1K +$96.3K +12,273 New
SAM
119
Shell Asset Management
Netherlands
$59K +$66.8K +8,505 New
Osaic Holdings
120
Osaic Holdings
Arizona
$58.9K -$80.8K -10,295 -55%
National Bank of Canada
121
National Bank of Canada
Quebec, Canada
$42.7K -$4.72K -602 -9%
Fidelity Investments
122
Fidelity Investments
Massachusetts
$40.6K +$1.89K +241 +4%
NFSG
123
Newbridge Financial Services Group
Florida
$34.7K
NC
124
nVerses Capital
Florida
$33.3K +$37.7K +4,800 New
BCMLT
125
Beacon Capital Management LLC (Tennessee)
Tennessee
$27.8K

GDRX Hedge Fund Activity: Q3 2024 in Review

168 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2024, worth a combined $988M — down 4% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new GDRX positions and 32 closed out — a net gain of 6 holders — while 40 added to existing stakes and 46 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $29.9M. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $5.35M sold.

  • 168 institutional investors held GoodRx Holdings (GDRX) as of Q3 2024, up from 165 in Q2 2024.
  • Funds reported $988M of GoodRx Holdings stock for Q3 2024, down 4% quarter-over-quarter.
  • 38 funds opened new GoodRx Holdings positions in Q3 2024 and 32 closed out, a net change of +6 holders.
  • The largest GoodRx Holdings buyer in Q3 2024 was T. Rowe Price Investment Management, an estimated $29.9M added.
  • The largest GoodRx Holdings seller in Q3 2024 was Schroder Investment Management Group, an estimated $5.35M sold.

Based on aggregated 13F filings for Q3 2024.